Toyota is not out of the woods yetToyota has one more leg down to major support zone at 6209-6263 before a stronger rally occurs. Reason? First, the formation of evening star at 123.6% extension level indicate a false breakout. And prices close at the major support level. As such, there is a strong desire for Toyota to test lower lows.
$2413:TSE - M3 INC - Up 125% over the last 12 monthsM3 Has been having a good run but momentum has slowed. Viewing it with a Bollinger Bands overlay shows a bit of compression happening so will be interesting to see which way it breaks.
M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Portal, Evidence Solutions, Overseas, Clinical Platform, and Others. The Medical Portal segment provides the medical-related marketing support and research services. The Evid
$4776:TSE - CYBOZU INC - Up 135% over 12 monthsCybozu based in Japan is a provider of SAAS, CRM and HR type solutions. Has had a pullback back to a previous support area so might be worth keeping an eye on to see if it heads back up. Would want to wait for confirmation though. Just on the watch list for now.
$3635:TSE - KOEI TECMO HOLDINGS - Japanese Gaming CompanyKoei traded on the Tokyo exchange seems to be in a nice steady uptrend with fairly minimal volatility. Could be worth a look.
Koei Tecmo Holdings Co., Ltd. engages in game software development. It operates through the following business segments: Entertainment, SP, Amusement Facility Operations, Real Estate, and Others. The Entertainment segment develops and sells entertainment contents for personal computers, family consoles, online games, and smartphone applications. The SP segment develops t
4519:TSE - CHUGAI PHARMACEUTICAL - Up 145% over 12 months.Japanese listed Chugai Pharmaceutical is in a nice steady up trend. Could be worth a watch.
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety. The Research division focuses its efforts on creating innovative drugs by using its competitive strengths that























